An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution

The xenobiotic metabolizing cytochromes P450 (P450s) are among the most versatile biological catalysts known, but knowledge of the structural basis for their broad substrate specificity has been limited. P450 2B4 has been frequently used as an experimental model for biochemical and biophysical studies of these membrane proteins. A 1.6-Å crystal structure of P450 2B4 reveals a large open cleft that extends from the protein surface directly to the heme iron between the α-helical and β-sheet domains without perturbing the overall P450 fold. This cleft is primarily formed by helices B′ to C and F to G. The conformation of these regions is dramatically different from that of the other structurally defined mammalian P450, 2C5/3LVdH, in which the F to G and B′ to C regions encapsulate one side of the active site to produce a closed form of the enzyme. The open conformation of 2B4 is trapped by reversible formation of a homodimer in which the residues between helices F and G of one molecule partially fill the open cleft of a symmetry-related molecule, and an intermolecular coordinate bond occurs between H226 and the heme iron. This dimer is observed both in solution and in the crystal. Differences between the structures of 2C5 and 2B4 suggest that defined regions of xenobiotic metabolizing P450s may adopt a substantial range of energetically accessible conformations without perturbing the overall fold. This conformational flexibility is likely to facilitate substrate access, metabolic versatility, and product egress.

[1]  M. J. Coon,et al.  Interactions of cytochrome P-450, NADPH-cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system. , 1980, The Journal of biological chemistry.

[2]  D E McRee,et al.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.

[3]  T. Poulos,et al.  Structure of a cytochrome P450-redox partner electron-transfer complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[5]  S. Sligar,et al.  Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Halpert,et al.  Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles. , 2001, Molecular pharmacology.

[7]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[8]  J. Halpert,et al.  Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis. , 2001, Current drug metabolism.

[9]  J. Halpert,et al.  A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function. , 2001, Archives of biochemistry and biophysics.

[10]  A. Dunn,et al.  Probing the open state of cytochrome P450cam with ruthenium-linker substrates , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Eric F. Johnson,et al.  Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5. , 2002, Methods in Enzymology.

[12]  M. J. Coon,et al.  Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[13]  I. Vakser,et al.  Identification of the Binding Site on Cytochrome P450 2B4 for Cytochrome b 5 and Cytochrome P450 Reductase* , 1998, The Journal of Biological Chemistry.

[14]  C David Stout,et al.  Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding. , 2003, Biochemistry.

[15]  T. Poulos,et al.  The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.

[16]  M. J. Coon,et al.  Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Eric F. Johnson,et al.  Engineering Microsomal Cytochrome P450 2C5 to Be a Soluble, Monomeric Enzyme , 2000, The Journal of Biological Chemistry.

[18]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[19]  D E McRee,et al.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.

[20]  Slobodan Petar Rendic Summary of information on human CYP enzymes: human P450 metabolism data , 2002, Drug metabolism reviews.

[21]  C David Stout,et al.  Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. , 2003, Biochemistry.

[22]  P. Axelsen,et al.  Interactions of substrate and product with cytochrome P450: P4502B4 versus P450cam. , 1998, Archives of biochemistry and biophysics.

[23]  M. J. Coon,et al.  Membrane topology of cytochrome P450 2B4 in Langmuir-Blodgett monolayers. , 1998, Archives of biochemistry and biophysics.

[24]  T. Poulos,et al.  Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. J. Coon,et al.  BIOCHEMICAL STUDIES ON CYTOCHROME P‐450 SOLUBILIZED FROM LIVER MICROSOMES: PARTIAL PURIFICATION AND MECHANISM OF CATALYSIS * , 1973, Annals of the New York Academy of Sciences.

[26]  G. Sheldrick Phase annealing in SHELX-90: direct methods for larger structures , 1990 .

[27]  Benjamin A. Neely,et al.  The 1.92-Å Structure of Streptomyces coelicolor A3(2) CYP154C1 , 2003, The Journal of Biological Chemistry.